BeiGene
BGNE
#912
Rank
ยฃ17.38 B
Marketcap
ยฃ154.38
Share price
0.15%
Change (1 day)
2.79%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company